therapeutic action: antiviral activity

Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies

mycolabadmin

This editorial highlights the growing problem of fungal infections that resist current treatments, causing millions of deaths worldwide each year. Researchers are finding new ways to fight these resistant infections by repurposing existing drugs in new combinations and discovering novel compounds from natural sources. The collection of studies presented shows promising results using combinations like minocycline with antifungal drugs, natural compounds like baicalin, and AI technology to predict resistance patterns. These innovative approaches offer hope for better treatment options for patients suffering from serious fungal infections.

Read More »

Energy Metabolism Enhance Perylenequinone Biosynthesis in Shiraia sp. Slf14 through Promoting Mitochondrial ROS Accumulation

mycolabadmin

Scientists studied two similar fungi to understand how one produces more of a beneficial compound called perylenequinones (PQs), which have medical uses against infections and cancer. They discovered that the high-producing strain uses energy more efficiently, which causes tiny structures in the cells called mitochondria to produce reactive molecules (ROS). These reactive molecules trigger the fungus to make more PQs as a protective response. By controlling these processes, researchers can potentially improve the production of this valuable medicine.

Read More »

A concise review of mushrooms antiviral and immunomodulatory properties that may combat against COVID-19

mycolabadmin

This review explores how medicinal mushrooms have compounds that could help fight COVID-19 and boost immune function. Various mushroom species contain natural substances like beta-glucans and polysaccharides that have shown antiviral properties and can strengthen the body’s immune response. The research suggests these mushrooms could potentially be used alongside conventional treatments to help patients recover from COVID-19 more effectively.

Read More »

Whole genome sequencing and annotations of Trametes sanguinea ZHSJ

mycolabadmin

Scientists sequenced the complete genome of Trametes sanguinea, a medicinal mushroom used in traditional Chinese medicine, grown in China. The mushroom’s tissue contains beneficial compounds that may help fight tumors, protect the heart, boost immunity, and heal diabetic wounds. By mapping out all 10,886 genes in this fungus, researchers now have detailed blueprints to understand how it produces these healing compounds and potentially grow them industrially for medical use.

Read More »

Saponins, the Unexplored Secondary Metabolites in Plant Defense: Opportunities in Integrated Pest Management

mycolabadmin

Plants naturally produce compounds called saponins that protect them from insects, fungi, bacteria, parasitic worms, and viruses. This review explains how saponins work as natural pest managers and discusses how plants rich in saponins, such as licorice and soapbark trees, could be used to develop environmentally friendly crop protection products instead of synthetic pesticides.

Read More »

Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris

mycolabadmin

Researchers tested an edible mushroom called Cordyceps militaris to see if it could fight SARS-CoV-2, the virus that causes COVID-19. Using computer modeling and laboratory experiments, they found that a compound in the mushroom called cordycepin strongly attached to the virus’s spike protein and reduced viral numbers by about 50% in cell cultures. The study supports traditional uses of this mushroom and suggests it could be helpful in managing COVID-19 as the disease becomes endemic.

Read More »

Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau

mycolabadmin

Researchers tested extracts from traditional Tibetan medicinal plants, mushrooms, and lichens to see if they could fight influenza virus. They found that seven out of nine extracts could reduce influenza virus infection in laboratory cells, with a mushroom extract called Armillaria luteo-virens showing particularly strong antiviral effects. These results suggest that traditional medicinal materials from the Qinghai–Tibetan plateau could be valuable sources for developing new flu treatments that might work better against drug-resistant flu strains.

Read More »
Scroll to Top